Speaker:
Prof. Giulio Caracciolo
- 'Sapienza' University of Rome
Monday, April 3, 2017
at
2:30 PM
sala verde
Despite the advances in biomedical applications of nanoparticles and numerous publications, few nanoparticles have made it to clinical trials and even fewer have reached clinical practice. This wide gap between bench discoveries and clinical applications is mainly because of our limited understanding of the biological identity of nanoparticles.
In biological environments (e.g. blood, saliva, interstitial fluids etc.), nanoparticles are coated by a ‘protein corona’, critically affecting physiological and therapeutic responses. In this talk, we highlight the emerging applications of protein corona towards its use in therapeutics and diagnostics. In particular, special emphasis is given to the exploitation of protein corona for targeted delivery of nanomaterials and early cancer detection. By highlighting such recent applications of protein corona, we hope to demonstrate that this bio-entity has the potential to determine the future success of nanoparticles in biomedicine beyond their currently envisioned purposes.
- Programme Director
-
-
External reference
-
- Publication date
-
March 23, 2017
pdf (it, 152 KB, 23/03/17)
